NASDAQ:AUPH (Aurinia Pharmaceuticals Inc.)

About AUPH

Aurinia is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. In January 2021, the Company introduced LUPKYNIS® (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. Aurinia is also developing aritinercept, a dual inhibitor of B cell-activating factor (BAFF) and a proliferation-inducing ligand (APRIL) for the potential treatment of autoimmune diseases.
  • Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) Latest News

    Coronavirus

    3 TSX Stocks Bay Street Expects Could Double or Triple in 1 Year!

    There are lots of TSX stocks out there that continue to be a deal, but these three offer the best…

    Read more »

    Investing

    Value Investors: 1 Pharma Growth Stock With Huge Potential

    Aurinia Pharmaceuticals Inc. (TSX:AUP)(NASDAQ:AUPH) has an extensive granted patent portfolio which makes the company's stock very valuable.

    Read more »

    Stocks for Beginners

    3 Top Canadian Pharma Stocks for Ambitious Investors

    Pharma stocks like Zymeworks Inc. (TSX:ZYME)(NYSE:ZYME) are coming into their own, offering growth investors a lot of upside potential.

    Read more »

    Top TSX Stocks

    3 BioPharm Stocks Yielding 100% Yearly Returns

    Zymeworks Inc. (TSX:ZYME)(NYSE:ZYME), among other Canadian biopharmaceutical companies, has been hit with shorter supplies and rising demand.

    Read more »

    Investing

    3 Stocks That Could Benefit From Canada’s Population Boom

    Stocks like Equitable Group Inc. (TSX:EQB) should benefit from long-term population growth in Canada.

    Read more »

    hospital, aged care facility
    Investing

    Which Canadian Healthcare Stocks Could Make You Rich?

    Sienna Senior Living Inc. (TSX:SIA) and two other Canadian healthcare stocks are performing very differently on the TSX. Are they…

    Read more »

    The Motley Fool
    Investing

    This Unloved Drug Stock Could Have Massive Upside

    Aurinia Pharmaceuticals Inc. (TSX:AUP)(NASDAQ:AUPH) is over-priced, but should that stop you owning one of the most stable high-growth stocks on…

    Read more »

    Investing

    3 High-Performing Stocks to Buy on the Dip

    Air Canada (TSX:AC)(TSX:AC.B) and these two other stocks have had strong performances this year, although they have been on the decline…

    Read more »

    Investing

    TSX Reaches 16,000: These Are 5 of the Highest-Performing Stocks This Year

    These five stocks, including Ballard Power Systems Inc. (TSX:BLDP)(NASDAQ:BLDP), have outperformed.

    Read more »

    Dividend Stocks

    3 Stocks That Have Soared Higher Than Shopify Inc. This Year!

    Aurinia Pharmaceuticals Inc. (TSX:AUP)(NASDAQ:AUPH) and these two other stocks have seen their share prices more than double in 2017.

    Read more »